EcoDrugPlus

Ensembl ID : ENSUMAG00000021488
Gene Symbol: RPL29
1 Cross references
206 Possible Orthologues:

24-Dehydrocholesterol Reductase

Ensembl ID : ENSUMAG00000022238
Gene Symbol: DHCR24
4 Cross references
208 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 6-Like

Ensembl ID : ENSUMAG00000010993
Gene Symbol: LOC103668940
3 Cross references
211 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase

Ensembl ID : ENSUMAG00000007258
Gene Symbol: HMGCR
4 Cross references
270 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1

Ensembl ID : ENSUMAG00000022869
Gene Symbol: PDPK1
4 Cross references
240 Possible Orthologues:

4-Hydroxyphenylpyruvate Dioxygenase

Ensembl ID : ENSUMAG00000005553
Gene Symbol: HPD
4 Cross references
204 Possible Orthologues:

40s Ribosomal Protein S21

Ensembl ID : ENSUMAG00000019963
Gene Symbol: LOC103673109
3 Cross references
183 Possible Orthologues:

5-Hydroxytryptamine Receptor 1b

Ensembl ID : ENSUMAG00000015515
Gene Symbol: HTR1B
4 Cross references
245 Possible Orthologues:

5-Hydroxytryptamine Receptor 1d

Ensembl ID : ENSUMAG00000013296
Gene Symbol: HTR1D
4 Cross references
67 Possible Orthologues:

5-Hydroxytryptamine Receptor 1e

Ensembl ID : ENSUMAG00000010350
Gene Symbol: HTR1E
4 Cross references
155 Possible Orthologues:

5-Hydroxytryptamine Receptor 1f

Ensembl ID : ENSUMAG00000001952
Gene Symbol: HTR1F
4 Cross references
145 Possible Orthologues:

5-Hydroxytryptamine Receptor 2a

Ensembl ID : ENSUMAG00000017217
Gene Symbol: HTR2A
4 Cross references
218 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).